Cons of Using GLP-1 for Weight Loss 1
As the disease progressed, patients would often switch or add therapies to maintain control
Immunity 55 , 3155 (2022)
According to FDA labeling and American Diabetes Association guidance, the risk of hypoglycemia is significantly higher when tirzepatide is used with insulin or sulfonylureas compared to tirzepatide monotherapy
At clinical doses under supervision, the most common side effects are mild nausea in the first week (typically resolves by day 7 to 10), injection site reactions (redness, minor swelling, localized soreness lasting 24 hours), and occasional transient fatigue or mild headache in the first few days
However, reimbursement depends heavily on medical necessity documentation and the specific service being billed alongside it